Company Overview and News
SANTA MONICA, Calif. and TORONTO, June 18, 2018 (GLOBE NEWSWIRE) -- The Tinley Beverage Company Inc. (the “Company" or "Tinley") is pleased to announce that it has appointed Curt Marvis to its board of directors. The Company has also released its cannabis margarita to a broader base of dispensaries following a successful initial commercial test.
QYOUF NEUL TNYBF QRSRF NLN TNY
SANTA MONICA, Calif. and TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- The Tinley Beverage Company Inc. (the “Company" or "Tinley") (CSE:TNY) (OTCQX:TNYBF) is pleased to announce that long-time Cott Board and Executive member Mark Benadiba, and California cannabis industry leader Ben Knight have joined the Company’s advisory board.
TNYBF COT QRSRF E ABCO BCB ETOLF TNY
SANTA MONICA, Calif. and TORONTO, April 19, 2018 (GLOBE NEWSWIRE) -- The Tinley Beverage Company Inc. (the “Company" or "Tinley") is pleased to announce that CMX Distribution has signed a definitive agreement to carry TinleyTM cannabis-infused products throughout California, and it has taken delivery of an initial batch of the Company’s first two cannabis-infused beverages.
TNYBF QRSRF TNY
TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Lineage Grow Company Ltd. (the "Company" or "Lineage"), (CSE:BUDD) announces the departure of David Drutz from his role as Chief Executive Officer (CEO) and president, effective immediately. Mr. Peter Bilodeau will be assuming the role of interim CEO and president. Mr. Bilodeau is the former CEO of Lakeside Minerals Inc., whose name was changed to Lineage Grow Company Ltd.
TWMJF TNYBF EAT RLV QRSRF WEED SPLIF LAK TNY
SANTA MONICA, Calif. and TORONTO, April 04, 2018 (GLOBE NEWSWIRE) -- The Tinley Beverage Company Inc. (the “Company" or "Tinley") (CSE:TNY) (OTCQX:TNYBF) (formerly OTC:QRSRF) is pleased to announce that it has produced an initial batch of its TinleyTM Cocktails cannabis margarita. Tinley is also pleased to announce that a leading licensed distributor has agreed in principle to carry Tinley cannabis-infused products throughout California, and it is working towards a definitive distribution agreement in time for the anticipated release of the product.
TNYBF QRSRF TNY
TORONTO, March 26, 2018 (GLOBE NEWSWIRE) -- Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV:DM) (FSE:D4G) is pleased to announce the appointment of David Posner to the board of Graph Blockchain Limited. Mr. Posner is an accomplished executive in the cannabis sector with strong public markets experience. Mr. Posner served as Chief Executive Officer and President at Nutritional High International Inc.
TNYBF EAT QRSRF SPLIF TNY
2018-06-24 - Asif
History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...